Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 2 for:    AZD2820
Previous Study | Return to List | Next Study

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmakodynamics of AZD2820 After Multiple Ascending Doses

This study has been terminated.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: September 30, 2011
Last updated: July 23, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)